Filana Therapeutics, Inc. (FLNA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Filana Therapeutics, Inc. (FLNA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

FLNA Income Statement

Filana Therapeutics, Inc. (FLNA) annual income statement — 27-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	300K	243K	367K	0	0	0	0	0	300K	16.23M	18.73M	23.6M	392K	22.12M	17.65M	18.53M	16.95M	14.91M	10.34M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-300K	-243K	-367K	0	0	0	0	0	-300K	-16.23M	-18.73M	-23.6M	-392K	-22.12M	-17.65M	-18.53M	-16.95M	-14.91M	-10.34M
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	100%	-	-	-	-	26.61%	-6.11%	-27.4%	97.69%	-48.4%	-70.68%	-130.39%	-334.45%	-489.4%	-580.84%
Operating Expenses	11.27M	9.09M	10.93M	13.19M	11.86M	45.39M	24.59M	29.49M	30.62M	66.9M	3.7M	4.06M	4.28M	28.39M	4.39M	3.29M	2.82M	2.97M	2.92M	4.1M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	7.41M	5.79M	6.38M	9.33M	7.91M	40.28M	10.92M	8.96M	12.95M	51.7M	6.7M	3.96M	4.28M	3.81M	4.39M	3.29M	2.82M	2.97M	2.92M	4.1M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	3.87M	3.3M	4.54M	3.85M	3.96M	5.12M	13.67M	20.53M	17.68M	15.2M	16.23M	18.73M	23.6M	24.97M	22.12M	18.55M	18.53M	17.35M	15.01M	14.24M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	-1000K	-1000K	-1000K	-392K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	0	-9.39M	-11.17M	-13.55M	-11.86M	-45.39M	-24.59M	-29.49M	-30.62M	-67.2M	-19.93M	-22.79M	-27.88M	-28.78M	-26.51M	-20.94M	-21.34M	-19.92M	-17.82M	-14.44M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	100%	79.31%	54.58%	54.04%	61.27%	32.45%	-	-	-	-	24.81%	-8.85%	-30.61%	-44.48%	-48.77%	-44.95%	-118.86%	-287.64%	-404.42%	-450.46%
EBITDA	0	-9.09M	-10.93M	-13.19M	-11.73M	-45.17M	-24.37M	-29.23M	-30.36M	-66.9M	-19.62M	-22.43M	-27.49M	-28.39M	-26.12M	-20.55M	-21.05M	-19.62M	-17.51M	-14.13M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	100%	79.87%	55.16%	54.89%	61.37%	32.48%	-	-	-	-	24.88%	-9.17%	-30.61%	-44.69%	-49.19%	-45.41%	-120.57%	-282.42%	-395.7%	-438.73%
D&A (Non-Cash Add-back)	0	300K	243K	367K	131K	218K	220K	260K	259K	300K	311K	356K	392K	391K	391K	389K	300K	299K	313K	313K
EBIT	0	-9.39M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-30.32M	-27.94M	-67.2M	-22.93M	-22.69M	-27.88M	-28.78M	-26.51M	-20.94M	-21.34M	-19.92M	-17.82M	-14.44M
Net Interest Income	0	747K	789K	974K	1.17M	1.21M	1.26M	1.8M	2.62M	2.32M	1.78M	1.58M	2M	2.2M	2.05M	1.55M	878K	314K	31K	14K
Interest Income	520K	747K	789K	974K	1.17M	1.21M	1.26M	1.8M	2.62M	2.32M	1.78M	1.58M	2M	2.2M	2.05M	1.55M	878K	314K	31K	14K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	0	790K	837K	1.01M	1.05M	1.17M	1.18M	1.89M	2.68M	73.36M	44.98M	1.87M	2.23M	2.4M	2.24M	1.8M	1.09M	589K	294K	272K
Pretax Income	-10.73M	-8.6M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-27.6M	-27.94M	6.16M	25.04M	-20.92M	-25.65M	-26.38M	-24.27M	-19.13M	-20.26M	-19.33M	-17.53M	-14.17M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-10.73M	-8.6M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-27.6M	-27.94M	6.16M	25.04M	-20.92M	-25.65M	-26.38M	-24.27M	-19.13M	-20.26M	-19.33M	-17.53M	-14.17M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.75%	80.55%	55.86%	54.56%	61.32%	-818.51%	-	-	-	-	203.18%	-9.33%	-26.63%	-36.47%	-38.48%	-35.01%	-111.85%	-277.13%	-397.08%	-441.33%
Net Income (Continuing)	-10.73M	-8.6M	-10.33M	-12.54M	-10.81M	-44.22M	-23.4M	-27.6M	-27.94M	6.16M	25.04M	-20.92M	-25.65M	-26.38M	-24.27M	-19.13M	-20.26M	-19.33M	-17.53M	-14.17M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.22	-0.18	-0.21	-0.26	-0.22	-0.92	-0.48	-0.57	-0.58	0.13	-0.43	-0.50	-0.61	-0.63	-0.52	-0.43	-0.48	-0.46	-0.43	-0.35
EPS Growth %	0%	80.43%	56.25%	54.39%	62.07%	-807.69%	-	-	-	-	17.31%	-16.28%	-27.08%	-36.96%	-20.93%	-22.86%	-100%	-253.85%	-359.89%	-303.23%
EPS (Basic)	-0.22	-0.18	-0.21	-0.26	-0.22	-0.92	-0.48	-0.57	-0.58	0.13	0.58	-0.50	-0.61	-0.63	-0.52	-0.43	-0.48	-0.46	-0.43	-0.35
Diluted Shares Outstanding	48.46M	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	4.81B	47.98M	46.2M	44.1M	42.19M	42M	41.79M	41.74M	40.77M	40.05M	40.02M	39.96M	39.96M
Basic Shares Outstanding	48.46M	48.31M	48.31M	48.31M	48.31M	48.31M	48.26M	48.1M	47.98M	46.2M	43M	42.19M	42M	41.79M	41.74M	40.77M	40.05M	40.02M	39.96M	39.96M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-